| 000 | 01118nam a22003017a 4500 | ||
|---|---|---|---|
| 999 |
_c3762 _d3762 |
||
| 001 | ZFP | ||
| 003 | 9456 | ||
| 005 | 20260128043109.0 | ||
| 008 | 220302b xxu||||| |||| 00| | eng d | ||
| 020 | _a 978-0849377846 | ||
| 040 | _cZFP | ||
| 050 | _aQV38 | ||
| 100 |
_aKanfer, Isadore _95978 |
||
| 245 | _aGeneric Drug Product Development : bioequivalence issues / | ||
| 260 |
_bInforma Healthcare , _c2008 . _aNew York : |
||
| 300 | _aX, 264 p. | ||
| 504 | _aIncludes Bibliographical References | ||
| 650 |
_aDrugs _xTherapeutic equivalency _917331 |
||
| 650 |
_aGeneric drugs _917587 |
||
| 650 |
_aDrugs _xBioavailability _917330 |
||
| 650 |
_aPharmaceutical industry _94970 |
||
| 650 |
_aDrug development _94919 |
||
| 650 |
_aDrugs _xLaw and legislation _917077 |
||
| 650 |
_aDrugs _xTesting _94701 |
||
| 700 |
_aShargel, Leon _91804 |
||
| 856 | _uhttps://books.google.com.pk/books?id=61TvBQAAQBAJ&printsec=frontcover&dq=Generic+drug+product+development+:+bioequivalence+issues&hl=en&sa=X&redir_esc=y#v=onepage&q=Generic%20drug%20product%20development%20%3A%20bioequivalence%20issues&f=false | ||
| 942 |
_cBK _2NLM |
||